Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Eur Psychiatry ; 23(1): 8-13, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17964764

RESUMO

It is not clear whether patient's psycho-education enhances compliance to antipsychotic treatments and reduces the number of relapses. Here we investigated the impact of a new psycho-educational program (SOLEDUC) on the one- and two-years rate of relapse (primary outcome measure) and a number of clinical assessments (secondary outcome measures). This was a multicentric French clinical trial (51 centers) of Phase IV, open, controlled, randomized, consisting in two parallel groups: the Soleduc group (N=111) and the control group (N=109). All subjects received a variable dose over the 2-year period of the same antipsychotic drug (amisulpride). Soleduc consisted of a 7-session program (1h per session), presented three times (at baseline, 6-months and 12-months). Patients in the control group received a non-specific psychosocial training for an equivalent period of time. The models of Andersen-Gill (AG) and Prentice, Williams and Peterson (PWP) were used to analyze relapses. Patients in the Soleduc group attended 14.8+/-6.1 sessions (mean+/-SD), including 17 patients who never attended a session. Intent to treat analysis showed less patients relapsing in the Soleduc group as compared to the control group (21.6% versus 28.4% after 1 year and 84.4% versus 90.8% after 2years), but the differences were not statistically significant. Relapse risk was significantly reduced for patients who followed at least 7 modules (p=0.015 AG-test; p<0.001 PWP-test). In conclusion, no significant differences in relapse rates were found between patients attending the Soleduc program and the control group. Attendance of at least 7 out of 21 program sessions was required to see a modest, but significant two-year relapse prevention in schizophrenia. Other well designed studies are required to evaluate the medical impact of patient's education programs.


Assuntos
Antipsicóticos/uso terapêutico , Educação de Pacientes como Assunto/métodos , Esquizofrenia/tratamento farmacológico , Esquizofrenia/prevenção & controle , Psicologia do Esquizofrênico , Sulpirida/análogos & derivados , Adulto , Amissulprida , Ensaios Clínicos Fase IV como Assunto/estatística & dados numéricos , Grupos Controle , Feminino , Humanos , Masculino , Prognóstico , Escalas de Graduação Psiquiátrica/estatística & dados numéricos , Psicoterapia/métodos , Esquizofrenia/diagnóstico , Prevenção Secundária , Sulpirida/uso terapêutico , Resultado do Tratamento
2.
Bull Acad Natl Med ; 191(6): 1019-32; discussion 1032, 2007 Jun.
Artigo em Francês | MEDLINE | ID: mdl-18402162

RESUMO

Terrorism is a major public health concern. The impact of violence against the civilian population is reinforced by the media reporting. Thus, terrorism has a psychological impact not only on its direct victims but also on the population as a whole. More research is needed on how to manage these consequences.


Assuntos
Saúde Pública , Transtornos de Estresse Pós-Traumáticos , Estresse Psicológico , Terrorismo/psicologia , Adulto , Criança , França , Humanos , Meios de Comunicação de Massa , Opinião Pública
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA